Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 132 participants.
Also called NCT05294887
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 132 participants
- Registry
-
NCT05294887 -
2020-004717-12
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Switzerland
- Registry status
- Unknown status
Technical summary
Registry record NCT05294887. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-04 (actual); primary completion 2024-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
- Acronym
- EXAMINE-CAD
- Condition
- Coronary Microvascular Dysfunction
- Condition
- Microvascular Angina
- Condition
- Vasospasm, Coronary
- Condition
- Vasospastic Angina
- Condition
- Prinzmetal Angina
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Bisoprolol
- Intervention (Drug)
- Diltiazem
- Intervention (Drug)
- Placebo
- Lead sponsor
- Charite University, Berlin, Germany
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Record details
- Record id
cardio:ct-nct05294887- Content hash
2655455662d1e2a6d895f884a7646a17fe21c4812af665cd070f0e2d6f7260b6